RWM
IRWD icon

Ritholtz Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ritholtz Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Buy
+87,535
New +$359K 0.01% 963
2023
Q3 		– Sell
-79,532
Closed -$846K – 721
2023
Q2 		$846K Sell
79,532
-140
-0.2% -$1.5K 0.04% 313
2023
Q1 		$838K Buy
79,672
+8,508
+12% +$95.3K 0.04% 303
2022
Q4 		$882K Buy
71,164
+22,692
+47% +$257K 0.05% 254
2022
Q3 		$502K Buy
48,472
+37,348
+336% +$423K 0.03% 399
2022
Q2 		$128K Buy
+11,124
New +$131K 0.01% 514

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ritholtz Wealth Management's IRWD Position: Q1 2026 in Review

Ritholtz Wealth Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 87,535 shares worth $307K. The stake represents 0.01% of the portfolio and ranks #963 among its holdings. This is a return to the name: Ritholtz Wealth Management previously reported a position in IRWD as recently as Q2 2023.

Ritholtz Wealth Management first reported a position in IRWD in Q2 2022 and has held it in 6 quarters since. The position peaked at $882K in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Ritholtz Wealth Management held 87,535 shares of Ironwood Pharmaceuticals worth $307K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Ritholtz Wealth Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.01% of Ritholtz Wealth Management's portfolio in Q1 2026, its #963 holding.
  • Ritholtz Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
  • Ritholtz Wealth Management's Ironwood Pharmaceuticals position peaked at $882K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.